Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added Study Status entries dated 2026-01-12 and 2026-01-09 with Revision: v3.3.4; removed the 2025-10-03 entry and Revision: v3.3.3 from the history.
    Difference
    0.4%
    Check dated 2026-01-14T03:21:29.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3, and references to HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T21:21:45.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and Revision: v3.2.0 was removed from the Record History; these are site revision notes and do not affect trial data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:16.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice from the page.
    Difference
    0.6%
    Check dated 2025-11-18T07:12:39.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    The page history shows additional Study Status updates across multiple versions, indicating changes in the trial's recruitment and overall status over time.
    Difference
    0.1%
    Check dated 2025-11-03T21:10:18.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Updated operating status notice, current date, new study status, and new software revision (v3.2.0); removed older revision (v3.1.0) and an earlier date (2025-08-13).
    Difference
    13%
    Check dated 2025-10-06T05:49:46.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.